SAG-AFTRA and AMPTP Reach Tentative Four-Year Contract

SAG-AFTRA and the Alliance of Motion Picture and Television Producers reached a tentative agreement on terms for a successor contract to the 2023 SAG-AFTRA TV/Theatrical Contracts. The agreement covers motion pictures, scripted primetime dramatic television, streaming content, and new media. SAG-AFTRA has approximately 160,000 members.

The tentative agreement includes AI protections. The tentative agreement is a four-year agreement. The tentative agreement is heading to the SAG-AFTRA national board for review.

The SAG-AFTRA national board will meet in the coming days to review terms. Negotiations between SAG-AFTRA and AMPTP began on February 9, 2026. Negotiations recessed on March 15, 2026, to allow for the WGA deal.

Negotiations resumed on April 27, 2026. Negotiations concluded on May 2, 2026. SAG-AFTRA established standards for AI-related consent and compensation during its 2023 negotiations.

Duncan Crabtree-Ireland is SAG-AFTRA's chief negotiator. Sean Astin is SAG-AFTRA president. The Writers Guild of America settled a four-year contract with AMPTP. Hessinger is the AMPTP’s chief negotiator.

The agreement will be evaluated by SAG-AFTRA members in a ratification vote that has yet to be scheduled. SAG-AFTRA received a sizable contribution to its pension fund from the AMPTP. The WGA agreed to a multi-million contribution to its healthcare plan from AMPTP last month.

AI guardrail measures were put in place between SAG-AFTRA and AMPTP. The DGA plans to sit down with the AMPTP on May 11, 2026.

““People need their wages; they’re having a hard time qualifying for health care. They need cost-of-living, inflation [adjustments]. People need to make more money,” SAG-AFTRA president Sean Astin previously told The Hollywood Reporter.”

““SAG-AFTRA and the AMPTP have reached a tentative agreement on terms for a successor contract to the 2023 SAG-AFTRA TV/Theatrical Contracts covering motion pictures, scripted primetime dramatic television, streaming content and new media,” SAG-AFTRA said in a statement posted to its website. Julia Vitarello's daughter Mila received a bespoke medicine eight years ago for her particular disease-causing mutation. Julia Vitarello is starting a new company to create individualized therapies at scale. Julia Vitarello's previous effort, EveryONE Medicines, folded recently. Miron Muslić signed a new deal with Schalke 04 until June 2028.”